Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 9, 2020Cochrane libraryOpen Access

(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2020 study studied this question.

synapsesocial.com/papers/6a7f80ffa9872118f46823f8https://doi.org/10.1002/14651858.cd005613.pub4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus2007 · 366 citations
  2. 2Design, objectives, execution and reporting of published open‐label extension studies2010 · 51 citations
  3. 3Risk Factors for Diabetic Peripheral Sensory Neuropathy: Results of the Seattle Prospective Diabetic Foot Study1997 · 369 citations
  4. 4Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.1985 · 438 citations